Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23612661 | 0.82 | — | — | |
| SCHEMBL18924230 | 0.81 | ALDH1A1 (0.44) | NPSR1MEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL21367460 | 0.78 | EPHX1 (0.31) | NPSR1MEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL23430275 | 0.74 | ALDH1A1 (0.39) | NPSR1MEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL18711192 | 0.74 | NPSR1 (0.34) | NPSR1MEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL19049860 | 0.74 | MEN1 (0.31) | NPSR1MEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL19961030 | 0.73 | ALDH1A1 (0.43) | NPSR1MEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL19808298 | 0.72 | HSD11B1 (0.37) | NPSR1MEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL21298725 | 0.72 | — | — | |
| SCHEMBL21135616 | 0.72 | EPHX2 (0.31) | NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11693313-B2 | Resist composition and method of forming resist pattern | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11693313-B2 | Resist composition and method of forming resist pattern | C1R, C1S, C9 | NPSR1 1322/4885MEN1 1250/4885ALDH1A1 1921/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.